Literature DB >> 3282011

A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin.

K Schmitt1, W Däubener, D Bitter-Suermann, U Hadding.   

Abstract

The antibacterial activity of ciprofloxacin, a 4-fluoroquinolone antibiotic, in the control of mycoplasma contamination in experimentally infected cell lines has been investigated. Seven mycoplasma species, including M. hyorhinis, M. gallisepticum, M. orale, M. salivarium, M. hominis, M. fermentans, and M. arginini, which had chronically infected the murine plasmocytoma line X63-Ag8 653, were eradicated with 10 micrograms/ml ciprofloxacin. Wild type laboratory infections of two human cell lines, HL-60 and U-937, were eliminated by 12 days of such treatment. Mycoplasma decontamination of cell cultures was monitored by the cultivation method 4 weeks after treatment. No side effects were seen in cell cultures and complex proliferation assays with cells of human and murine origin, using ciprofloxacin in doses up to 2.5 times the usual bactericidal concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282011     DOI: 10.1016/0022-1759(88)90437-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.

Authors:  C Somasundaram; W Nicklas; S Matzku
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

2.  The monomeric G-proteins Rac1 and/or Cdc42 are required for the inhibition of voltage-dependent calcium current by bradykinin.

Authors:  M A Wilk-Blaszczak; W D Singer; T Quill; B Miller; J A Frost; P C Sternweis; F Belardetti
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

3.  Evaluation of two methods for elimination of mycoplasma.

Authors:  K Hlubinová; J Prachar; A Feldsamová
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-01       Impact factor: 2.416

4.  Growth of mycoplasma transformed tTN129 cells depends on IGF-I.

Authors:  L T Van der Ven; L H Rademakers; A F Angulo; J C Giltay; I Wills; G H Jansen; I M Prinsen; A G Rombouts; P J Roholl; W Den Otter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

5.  Growth Dynamics and Antibiotic Elimination of Symbiotic Rickettsia buchneri in the Tick Ixodes scapularis (Acari: Ixodidae).

Authors:  Jonathan D Oliver; Lisa D Price; Nicole Y Burkhardt; Chan C Heu; Benedict S Khoo; Cody J Thorpe; Timothy J Kurtti; Ulrike G Munderloh
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

6.  The failure of Daudi cells to express the cellular prion protein is caused by a lack of glycosyl-phosphatidylinositol anchor formation.

Authors:  E Morelon; V Dodelet; P Lavery; N R Cashman; R Loertscher
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

7.  Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination.

Authors:  R C Feldmann; B Henrich; V Kolb-Bachofen; U Hadding
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

8.  Elimination of mycoplasmas from cell cultures by a novel soft agar technique.

Authors:  H Kotani; G Butler; D Heggan; G J McGarrity
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

9.  In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.

Authors:  M M Hayes; H H Foo; H Kotani; D J Wear; S C Lo
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens.

Authors:  W J Burlingham; S S Ceman; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.